Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral formulations of CD73 compounds

Oral formulations of CD73 compounds

US Patent 11633416 · Granted Apr 25, 2023

Estimated economic value: $22,893,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulators of 5′-nucleotidase, ecto and the use thereof2025
Modulators of 5′-nucleotidase, ecto and the use thereof2025
Modulators of 5′-nucleotidase, ecto and the use thereof2025
Parenterally administered immune enhancing drugs2025
Parenterally administered immune enhancing drugs2025
Parenterally administered immune enhancing drugs2025
Amorphous and crystalline forms of IDO inhibitors2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds2025
Thiazole compounds and methods of use thereof2025
Inhibitors of ARG1 and/or ARG22025